Aarti Pharmalabs Limited (NSE:AARTIPHARM)
India flag India · Delayed Price · Currency is INR
905.05
+14.70 (1.65%)
Jul 1, 2025, 1:30 PM IST

Aarti Pharmalabs Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020
Period Ending
Jun '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020
80,68967,90239,41824,999--
Upgrade
Market Cap Growth
72.26%72.26%57.68%---
Upgrade
Enterprise Value
84,25870,77140,89226,947--
Upgrade
Last Close Price
890.35749.25432.77273.41--
Upgrade
PE Ratio
29.6424.9318.1712.92--
Upgrade
PS Ratio
3.813.212.131.29--
Upgrade
PB Ratio
4.053.412.241.60--
Upgrade
P/TBV Ratio
4.273.592.351.65--
Upgrade
P/FCF Ratio
--64.8916.89--
Upgrade
P/OCF Ratio
24.3420.4818.229.99--
Upgrade
EV/Sales Ratio
3.983.352.211.39--
Upgrade
EV/EBITDA Ratio
18.1415.2410.597.88--
Upgrade
EV/EBIT Ratio
22.3218.7513.079.64--
Upgrade
EV/FCF Ratio
-119.56-67.3118.21--
Upgrade
Debt / Equity Ratio
0.210.210.160.140.250.08
Upgrade
Debt / EBITDA Ratio
0.890.890.740.631.65-
Upgrade
Debt / FCF Ratio
--4.701.46--
Upgrade
Asset Turnover
0.770.770.770.911.18-
Upgrade
Inventory Turnover
1.831.831.702.24--
Upgrade
Quick Ratio
1.111.110.900.860.8011.42
Upgrade
Current Ratio
2.012.011.941.941.7711.42
Upgrade
Return on Equity (ROE)
14.54%14.54%13.08%13.14%17.63%-2.00%
Upgrade
Return on Assets (ROA)
8.60%8.60%8.10%8.16%10.10%-1.15%
Upgrade
Return on Capital (ROIC)
10.61%10.61%10.25%9.98%11.92%-1.16%
Upgrade
Return on Capital Employed (ROCE)
16.80%16.80%16.60%17.00%11.30%-
Upgrade
Earnings Yield
3.38%4.01%5.50%7.74%--
Upgrade
FCF Yield
-0.87%-1.04%1.54%5.92%--
Upgrade
Dividend Yield
0.41%-0.69%0.73%--
Upgrade
Payout Ratio
11.64%11.64%8.36%9.37%--
Upgrade
Buyback Yield / Dilution
-0.05%-0.05%-0.01%--36150.40%-
Upgrade
Total Shareholder Return
0.36%-0.05%0.69%0.73%-36150.40%-
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.